Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS)
CNY 85.98
(-20.0%)
CNY 85.98
(-20.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 258.53 Million CNY | 58.81% |
| 2022 | 162.79 Million CNY | 5.13% |
| 2021 | 154.84 Million CNY | 5482.79% |
| 2020 | 2.77 Million CNY | 0.0% |
| 2019 | - CNY | -100.0% |
| 2018 | 894.45 Thousand CNY | -96.84% |
| 2017 | 28.27 Million CNY | 76.72% |
| 2016 | 16 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 583.87 Million CNY | 148.04% |
| 2024 Q1 | 264.5 Million CNY | -8.95% |
| 2023 Q4 | 258.53 Million CNY | 50.0% |
| 2023 FY | 258.53 Million CNY | 58.81% |
| 2023 Q2 | 171.16 Million CNY | 5.31% |
| 2023 Q1 | 162.52 Million CNY | -0.16% |
| 2023 Q3 | 172.35 Million CNY | 0.69% |
| 2022 Q3 | 164.18 Million CNY | -0.36% |
| 2022 Q1 | 156.58 Million CNY | 1.12% |
| 2022 FY | 162.79 Million CNY | 5.13% |
| 2022 Q4 | 162.79 Million CNY | -0.85% |
| 2022 Q2 | 164.78 Million CNY | 5.24% |
| 2021 Q2 | 20.78 Million CNY | 772.99% |
| 2021 FY | 154.84 Million CNY | 5482.79% |
| 2021 Q1 | 2.38 Million CNY | -14.16% |
| 2021 Q4 | 154.84 Million CNY | 53.42% |
| 2021 Q3 | 100.93 Million CNY | 385.61% |
| 2020 FY | 2.77 Million CNY | 0.0% |
| 2020 Q4 | 2.77 Million CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2019 FY | - CNY | -100.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 894.45 Thousand CNY | -96.84% |
| 2018 Q4 | - CNY | 0.0% |
| 2017 FY | 28.27 Million CNY | 76.72% |
| 2016 FY | 16 Million CNY | 0.0% |